|
Jim Healy, M.D., Ph.D., General Partner, joined Sofinnova in the spring of 2000. In the words of one entrepreneur, Jim has an "unparalleled work ethic." Prior to joining Sofinnova, he had experience with both pharmaceutical products and research platforms. In the pharmaceutical industry he held a manufacturing position at Bayer Pharmaceuticals (Miles) and helped guide the discovery group at ISTA Pharmaceuticals prior to its initial public offering. He also has experience with research tools and platforms through his involvement at the Human Genome Center at Lawrence Berkeley Labs. Jim has authored or co-authored numerous research articles and reviews, including three papers published in Nature. He began his private equity career at Sanderling. Jim earned B.A.s in Molecular Biology and Scandinavian Studies from the University of California at Berkeley, where he graduated with Distinction in General Scholarship, Honors, and received the Departmental Citation. Jim received his M.D. from Stanford School of Medicine through the Medical Scientist Training Program, and earned his Ph.D. in Immunology from Stanford University, where he was a Beckman Scholar and received a bursary award from the Novartis Foundation. | 